Mar 29, 2010 by Brian Orelli, PhD5 Drugmakers Producing Cash for YouTake greenbacks over earnings any day.
Mar 29, 2010 by Brian Orelli, PhD3 Drugmakers for the Risk-Averse InvestorMuch of the risk has been removed from these drugmakers.
Mar 29, 2010 by Brian Orelli, PhDLook for Companies That Strike FirstComparative trials are scary, but potentially profitable.
Mar 26, 2010 by Brian Orelli, PhDWhat Do Pfizer and the Mafia Have in Common?While illegal marketing of drugs might not be as bad as murder, it's still a crime.
Mar 25, 2010 by Brian Orelli, PhDMore Than $5.3 Billion in Revenue Under AttackAfter dealing with the FDA, Amgen and J&J now have to deal with CMS.
Mar 24, 2010 by Brian Orelli, PhDCrash! Another Roadblock for GenzymeThe FDA throws another obstacle on its road to recovery.
Mar 23, 2010 by Brian Orelli, PhDIcahn and Biogen Kiss and Make UpHe gets one more seat on the board, so what's next?
Mar 23, 2010 by Brian Orelli, PhDNo Patent! No Generics? Take Advantage of the SituationEnjoy it while it lasts, pharma.
Mar 22, 2010 by Brian Orelli, PhDNow That Health-Care Reform Is Over, Here's Where the Real Threat LiesIt's health reform 2.0 that you should be worried about.
Mar 22, 2010 by Brian Orelli, PhDHealth-Care Reform Passes! Here's Where to Invest NowSome healthy suggestions for your portfolio.
Mar 18, 2010 by Brian Orelli, PhDWhy Pfizer's Better Off Without RatiopharmIt's better to have lusted and lost than to have overpaid and won.
Mar 16, 2010 by Brian Orelli, PhDNo Matter What You Call It, It Still StinksA recall over a paperwork issue? What have you guys been doing?
Mar 16, 2010 by Brian Orelli, PhDHow to Lose $114 Million in One DayHype your company and then get the wrong answer from the FDA.
Mar 15, 2010 by Brian Orelli, PhDWarning: Not All Boxed Warnings Are EqualPlavix's is mild in comparison.
Mar 15, 2010 by Brian Orelli, PhDFDA Says "No Way!" Market Says "Yeah, Baby!"You can have it both ways.
Mar 15, 2010 by Brian Orelli, PhDClinical Outcomes? Who Needs 'Em.Abbott's TriCor looks good on lab tests, but that's about all.
Mar 12, 2010 by Brian Orelli, PhDPfizer's 3 Points of FailureMaybe April will be a better month for the drug giant.
Mar 12, 2010 by Brian Orelli, PhDInsurers to Washington: We're Not the ProblemInsurers say they're a small piece of the problem pie.
